Home > Insider Trading > Filing (0001209191-11-014071)

Filing Details

Accession Number:: 0001209191-11-014071
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-03-01 20:06:29
Reporting Period:: 2011-02-27

Filing Date:: 2011-03-01
Accepted Time:: 2011-03-01 20:06:29
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1180262	Herbalife Ltd.	HLF	Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1311173	Michael Johnson	800 W. Olympic Boulevard, #406 Los Angeles CA 90015	Chairman & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2011-02-27	7,032	$78.20	359,664	No	4	F	Direct
Common Stock	Disposition	2011-02-28	7,213	$78.41	352,451	No	4	F	Direct
Common Stock	Acquisiton	2011-03-01	122,061	$10.56	474,512	No	4	M	Direct
Common Stock	Disposition	2011-03-01	42,646	$75.25	431,866	No	4	S	Direct
Common Stock	Disposition	2011-03-01	42,200	$76.32	389,666	No	4	S	Direct
Common Stock	Disposition	2011-03-01	5,499	$76.99	384,167	No	4	S	Direct
Common Stock	Disposition	2011-03-01	4,901	$77.91	379,266	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	F	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Options (Right to Buy)	Disposition	2011-03-01	122,061	$0.00	122,061	$10.56

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2013-04-03	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	55,000	Indirect	Beneficially owned through Spouse's GRAT
Common Stock	55,000	Indirect	Beneficially owned through GRAT
Common Stock	56,561	Indirect	Beneficially owned through Michael O. Johnson IRA

Footnotes

Pursuant to the Issuer's 2005 Stock Incentive Plan and the terms of the related award agreement, shares of the Issuer's common stock are issued to the Reporting Person as his restricted stock units vest, with a portion of the newly issued shares automatically withheld by the Issuer to satisfy the resulting withholding tax obligation. This Statement of Changes of Beneficial Ownership has been filed to reflect that withholding of shares due to a recent vesting of restricted stock units held by the Reporting Person. The withholding of the newly issued shares occurred automatically upon the vesting of the restricted stock units, and as such, no investment decision was made by the Reporting Person in connection with this transfer.
Sale made pursuant to a pre-existing 10b5-1(c) trading plan publicly disclosed by the Issuer on November 9, 2009, under the headline "Herbalife Chairman and CEO Implements Orderly Stock Trading Plan; Will Retain Half of Net Proceeds in Company Stock."
This transaction was executed in multiple trades at prices ranging from $74.73 to $75.69. The price reported reflects the weighted average sale price of $75.25. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction waseffected.
This transaction was executed in multiple trades at prices ranging from $75.73 to $76.71. The price reported reflects the weighted average sale price of $76.32. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction waseffected.
This transaction was executed in multiple trades at prices ranging from $76.73 to $77.67. The price reported reflects the weighted average sale price of $76.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction waseffected.
This transaction was executed in multiple trades at prices ranging from $77.73 to $77.93. The price reported reflects the weighted average sale price of $77.91. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction waseffected.
These options were fully vested as of June 20, 2008.